Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

ClinicalTrials.gov ID: NCT01309542

Public ClinicalTrials.gov record NCT01309542. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 10 Month Open-Label Evaluation Of The Long-Term Safety Of DVS-233 SR In Outpatients With Major Depressive Disorder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study evaluated the long-term safety of Desvenlafaxine Succinate (DVS) Slow Release (SR) during open-label treatment in adult outpatients who had a primary diagnosis of major depressive disorder (MDD). The study also evaluated the long-term response of subjects receiving DVS SR for clinical global evaluation, functionality, general well-being, pain, and absence of depressive symptoms (remission).

Study identification

NCT ID
NCT01309542
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,403 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2003
Primary completion
Feb 28, 2006
Completion
Feb 28, 2006
Last update posted
Apr 25, 2011

2003 – 2006

United States locations

U.S. sites
53
U.S. states
25
U.S. cities
49
Facility City State ZIP Site status
Birmingham Research Group Inc. Birmingham Alabama 35216
Pivotal Research Centers 13128 North 94th Drive, Suite 200 Mesa Arizona 85210
Pivotal Research Peoria Arizona 85381
Southwestern Research, Inc. Beverly Hills California 90210
Feighner Research Institute Chula Vista California 91910
California Clinical Trials Medical Group, Inc. Glendale California 91206
Pharmacology Research Institute Newport Beach California 92660
Pacific Clinical Research Orange California 92868
UCSD Department of Psychiatry Psychopharmacology Research San Diego California 92103
Southwestern Research, Inc. Tustin California 92780
Alpine Clinical Research Center, Inc. Boulder Colorado 80304
Feiger Health Research Center Lakewood Colorado 80401
University of Connecticut Health Center Farmington Connecticut 06030-6415
New Britain General Hospital New Britain Connecticut 06050
The George Washington University Medical Center Washington D.C. District of Columbia 20037
CORE Research, Inc.1006 NW 14 Leesburg Florida 34748
Lifestream Behavioral Center Leesburg Florida 34748
Clinical Neuroscience Solutions, Inc. Orlando Florida 32819
Miami Research Associates, Inc. South Miami Florida 33143
Comprehensive NeuroScience, Inc. St. Petersburg Florida 33702
Kolin Research Group 1065 West Morse Blvd. Suite 202 Winter Park Florida 32789
Atlanta Center for Medical Research Atlanta Georgia 30308
Atlanta Institute of Medicine & Research Marietta Georgia 30060
Carman Research Smyrna Georgia 30080
Radiant Research - Chicago Chicago Illinois 60610
Ingenium Clinical Research Libertyville Illinois 60048
Capital Clinical Research Associates, LLP Rockville Maryland 20852
DuPont Clinical Research, Inc. Rockville Maryland 20852
Institute for Health Studies Okemos Michigan 48864
Creighton University Omaha Nebraska 68131
Center for Emotional Fitness Cherry Hill New Jersey 08002
CRI Worldwide, LLC Clementon New Jersey 08021
Social Psychiatry Research Institute New York New York 10021
The Medical Research Network New York New York 10024
Anxiety & Depression Clinic The Bronx New York 10467
Piedmont Neuropsychiatry Charlotte North Carolina 28226
Hartford Research Group Cincinnati Ohio 45242
Midwest Clinical Research Center, LLC Dayton Ohio 45408
Neurology & Neuroscience Center of Ohio Toledo Ohio 43623
IPS Research Company Oklahoma City Oklahoma 73103
Summit Research Network (Oregon), Inc. Portland Oregon 97210
Southeastern Pennsylvania Medical Institute Havertown Pennsylvania 19083
RI Mood & Memory Research Institute East Providence Rhode Island 02914
Southeast Health Consultants, LLC Charleston South Carolina 29407
Carolina Clinical Research Services Columbia South Carolina 29201
FutureSearch Trials Austin Texas 78756
University of Texas Southwestern Dallas Texas 75235
Research Testing, Inc. Houston Texas 77004
Radiant Research Salt Lake City Salt Lake City Utah 84107
Northwest Clinical Research Center Bellevue Washington 98007
Summit Research Network (Seattle) LLC Seattle Washington 98104
Center for Anxiety and Depression Seattle Washington 98105
Northbrooke Research Center Brown Deer Wisconsin 53223

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01309542, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2011 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01309542 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →